Literature DB >> 373945

Terminating a trial -- the ethical problem.

P Meier.   

Abstract

A comparative clinical trial will often lead to the conclusion that one regimen is clearly better than another. Should the estimated difference in the regimens be large and precisely determined, continuation of the trial would constitute abuse of the participants. Some earlier proposals for ethical decision making on continuing a trial are shown to be unsatisfactory, and a more general framework for dealing with the problem is proposed.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  1979        PMID: 373945     DOI: 10.1002/cpt1979255part2633

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  Experimental ethics in sports medicine research.

Authors:  D A Brodie; K Stopani
Journal:  Sports Med       Date:  1990-03       Impact factor: 11.136

2.  Paul Meier: a man behind the method.

Authors:  Kellyn Betts
Journal:  Am J Public Health       Date:  2012-09-20       Impact factor: 9.308

3.  Evaluating slow-acting antirheumatic drug therapies for rheumatoid arthritis.

Authors:  J R Ward; H J Williams; J C Reading; M J Egger
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

4.  Problems in controlled trials--a critical response.

Authors:  D W Vere
Journal:  J Med Ethics       Date:  1983-06       Impact factor: 2.903

5.  Basic problems in controlled trials.

Authors:  R Burkhardt; G Kienle
Journal:  J Med Ethics       Date:  1983-06       Impact factor: 2.903

6.  Statistics and ethics in medical research: study design.

Authors:  D G Altman
Journal:  Br Med J       Date:  1980-11-08

7.  Methodologic considerations for trials of lung cancer prophylaxis.

Authors:  A B Miller
Journal:  Can Med Assoc J       Date:  1980-04-05       Impact factor: 8.262

Review 8.  Integrating clinical and research psychiatry.

Authors:  J M de Groot; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

9.  Stopping rules, interim analyses and data monitoring committees.

Authors:  D Ashby; D Machin
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.